Skin Patch Shows Promise for Toddlers With Peanut Allergy
A global phase 3 clinical trial that included Ann & Robert H. Lurie Children's Hospital of Chicago found that a year-long immunotherapy through a skin patch safely desensitized toddlers with peanut allergy, lowering the risk of a severe allergic reaction from accidental exposure. Results of this randomized, double-blind, placebo-controlled trial for children 1-3 years of age, funded by DBV Technologies, were published in the New England Journal of Medicine.
"We were excited to contribute to this landmark study that carries so much promise for our young patients with peanut allergy," said co-author Melanie Makhija, MD, who was the Principal Investigator of the study at Lurie Children's and is an Associate Professor of Pediatrics at Northwestern University Feinberg School of Medicine. "Children who originally reacted to a small fraction of a peanut were able to tolerate the equivalent of one to four peanuts after completing the treatment course. This means that these children will be well protected from accidental exposure to peanuts. Importantly, we found that the peanut patch was safe, with very low chances of a severe allergic reaction. This is terrific news for families of kids with peanut allergies."
Peanut allergy affects approximately 2 percent of children in the United States, Canada and other westernized countries, and it commonly persists into adulthood. Life-threatening allergic reactions can be triggered by unintentional exposure to minute quantities, including through products manufactured on shared equipment as peanuts. Currently, there are no approved treatments for peanut-allergic children younger than 4 years of age.
Since 2012, the clinical trials program for food allergies at Lurie Children's has enrolled patients on numerous studies of novel treatments, including the oral immunotherapy for peanuts that has been approved by the Food and Drug Administration (FDA). Ongoing trials are available for all age groups, from infancy to young adulthood. The program is led by Principal Investigators Elizabeth Lippner, MD, and Abigail Lang, MD, MSCI.
Research at Ann & Robert H. Lurie Children's Hospital of Chicago is conducted through Stanley Manne Children's Research Institute. The Manne Research Institute is focused on improving child health, transforming pediatric medicine and ensuring healthier futures through the relentless pursuit of knowledge. Lurie Children's is a nonprofit organization committed to providing access to exceptional care for every child. It is ranked as one of the nation's top children's hospitals by U.S. News & World Report. Lurie Children's is the pediatric training ground for Northwestern University Feinberg School of Medicine.
Article by Science Daily.
------------------------------------------------------------------------------------------------
Pedagogy Education offers online continuing education courses in a variety of ways to meet your education goals and budget!
Courses may be purchased individually, or in packages (a bundle of courses, offered at a 10% discount). To view our entire catalog of education, click here. We offer a huge selection of infusion, vascular access, and state-specific IV "certification" courses!
We have annual memberships available to individuals or facilities who want to offer their staff access to a library of education for an entire year. Click here to view our Infusion and Vascular Access CE Membership. Facilities can visit our Annual Memberships to learn more about our nurse and nurse aide custom membership options and to view pricing!
Ready to purchase a course, package, or membership? Start here by creating your account! Want to receive our emails with notifications of new course releases and coupon codes good for discounts on courses? Sign up for our emails here. We would LOVE to have you join us on our social media pages, follow us on Facebook, LinkedIn, Instagram, and Pinterest. Watch out for exclusive promo codes!
